Exam 8: Treatment of Parkinsons Disease and Huntingtons Disease

_____ is a progressive disorder of the nervous system involving degeneration of dopaminergic neurons in the basal ganglia and nigrostriatal pathways in the brain.

After taking only the prescribed regimen of Sinemet (levodopa/carbidopa)for Parkinson's disease,Patient X has decided to discuss other drug treatment options with her physician to help lessen the excessive finger movements she has been experiencing.To help reduce the excessive finger movements,the physician may choose to _____.

MATCHING Match the following trade and generic names. -Tasmar

Which of the following would be used to increase DA levels?

Why should tyramine-containing foods be avoided by people taking MAOIs?

MATCHING Match the following trade and generic names. -Parlodel

Which of the following is not a common side effect of drugs used to treat Parkinson's disease?

Average onset of Parkinson's disease is _____ years.

Parkinson's disease is treated by all of the following except _____.

Why would adding carbidopa to levodopa increase levodopa bioavailability?

MATCHING Match the following trade and generic names. -Eldepryl

MATCHING Match the following trade and generic names. -Mirapex

Which of the following drugs can cause pseudoparkinsonism?

Exposure to _____ is an associated environmental cause in the development of Parkinson's disease.

Which of the following populations are most susceptible to adverse reactions to antiparkinsonian drugs?

What is the main difference between Parkinson's disease and Huntington's disease?

Symptoms of Parkinson's disease are a result of an imbalance between _____ and _____.

Which of the following is not a strategy for the treatment of Parkinson's disease?

Which of the following is a precursor to DA?

MATCHING Match the following trade and generic names. -Requip